Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
Job title: Reader in Cardiovascular Physiology
Personal History Dr Jamie O'Driscoll is based in Canterbury, UK where he holds the position of Reader in Cardiovascular Physiology at Canterbury Christ Church University. Academic History Dr Jamie O'Driscoll, BSc (Hons), MSc (Hons), CertEd, PhD, graduated with a 1st class honours in Sport Science from Brunel University, where he went on to earn a distinction in his MSc in Health and… View more
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF
Author(s): Naima Maqsood , Christian Ruff Added: 1 year ago
AHA 23 - Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews Dr Christian Ruff (Brigham and Women's Hospital, US) on the late-breaking findings from the AZALEA-TIMI 71 randomized trial (Anthos Theraputics, Inc).AZALEA-TIMI 71 aimed to evaluate the bleeding profile of abelacimab as compared to rivaroxaban in patients with atrial fibrillation who are at moderate to… View more

Anticoagulation

Electrophysiology & Arrhythmia
Radiation-associated Arrhythmias: A Focused Review
Author(s): Rohil Bedi , Ali Ahmad , Piotr Horbal , et al Added: 1 year ago

Electrophysiology & Arrhythmia

CV Disease in Special Populations
Jonathan Ho-Youn Kim
Job title: Director of Sports Cardiology
Dr Jonathan Kim is Director of Sports Cardiology and an Associate Professor of Medicine at Emory University Hospital, Atlanta. He also serves as Chair of the American College of Cardiology Sports and Exercise Cardiology Council.Dr Kim was completed his Doctor of Medicine degree at Vanderbilt University School of Medicine, Nashville. View more
Job title: Professor of Medicine and Director of Cardiovascular Research
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin
Author(s): Naima Maqsood , Jeff Healey Added: 1 year ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of… View more

Anticoagulation

Electrophysiology & Arrhythmia
Job title: Medical Director of Cardiac Rehabilitation and Preventive Cardiology and Director of Exercise Laboratories